MADISON WHORTON: Open Payments
NPI 1336682319 · TAYLORSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 44 payments from 13 companies in 2025. Trend: 2023 $33 · 2024 $576 · 2025 $864
Food & beverage: $819Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $184 |
| Novo Nordisk Inc | 7 | $146 |
| ABBVIE INC. | 10 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| PFIZER INC. | 2 | $53 |
| Inspire Medical Systems, Inc. | 2 | $53 |
| Noven Therapeutics, LLC | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
Products named: VRAYLAR, CAPLYTA, MOUNJARO, JARDIANCE, INSPIRE, Rybelsus, Ozempic, Xelstrym.
Industry payments across GA — which companies pay providers there.
